Baroldi Joseph's Form 4 filing
Ionis Pharmaceuticals Inc (IONS) · filed Jun 30, 2026
- Accession no.
- 0000874015-26-000218
- Filed
- Jun 30, 2026
- Trade date
- Jun 26, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $451.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Baroldi JosephCIK 0001813775 | Officer (EVP, Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | Common Stock | MOption exerciseAcquired | +3,866 | $56.78 | +$219,511.48 | 8,535 | Indirect | |
| Jun 26, 2026 | Common Stock | MOption exerciseAcquired | +1,769 | $32.60 | +$57,669.4 | 10,304 | Indirect | |
| Jun 26, 2026 | Common Stock | SSaleDisposed | −5,635 | $80.16 | −$451,701.6 | 4,669 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | Common Stock | MOption exerciseDisposed | −1,769 | $0.00 | $0 | 0 | Indirect | |
| Jun 26, 2026 | Common Stock | MOption exerciseDisposed | −3,866 | $0.00 | $0 | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.